Şeyda Gündüz

2.2k total citations
71 papers, 631 citations indexed

About

Şeyda Gündüz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Şeyda Gündüz has authored 71 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 21 papers in Surgery. Recurrent topics in Şeyda Gündüz's work include Cancer Immunotherapy and Biomarkers (10 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Gastric Cancer Management and Outcomes (5 papers). Şeyda Gündüz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Gastric Cancer Management and Outcomes (5 papers). Şeyda Gündüz collaborates with scholars based in Türkiye, United States and United Kingdom. Şeyda Gündüz's co-authors include Hasan Şenol Çoşkun, Rahmi Öklü, Hassan Albadawi, Mükremın Uysal, Hakan Bozcuk, Mustafa Yıldırım, Hakan Bozcuk, Ali Murat Tatlı, Vildan Kaya and Özlem Demirpençe and has published in prestigious journals such as Advanced Materials, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Şeyda Gündüz

68 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şeyda Gündüz Türkiye 16 241 173 155 84 79 71 631
Eurico Monteiro Portugal 15 207 0.9× 168 1.0× 227 1.5× 80 1.0× 123 1.6× 65 634
Xiaohui Huang China 12 165 0.7× 81 0.5× 146 0.9× 76 0.9× 187 2.4× 40 633
C. Anthony Howard United States 13 210 0.9× 196 1.1× 173 1.1× 125 1.5× 110 1.4× 19 750
Ryo Seishima Japan 14 263 1.1× 236 1.4× 133 0.9× 66 0.8× 122 1.5× 71 639
Rui Caetano Oliveira Portugal 15 223 0.9× 148 0.9× 100 0.6× 120 1.4× 172 2.2× 98 719
Nadine Saraiva Portugal 3 351 1.5× 186 1.1× 141 0.9× 50 0.6× 118 1.5× 6 619
Wilhelmina M. U. van Grevenstein Netherlands 19 459 1.9× 480 2.8× 162 1.0× 68 0.8× 72 0.9× 48 857
Christian J. Gabka Germany 11 218 0.9× 273 1.6× 102 0.7× 93 1.1× 123 1.6× 18 704
Hyun Soo Ahn South Korea 15 113 0.5× 181 1.0× 185 1.2× 45 0.5× 77 1.0× 55 599
Jennifer Q. Zhang United States 16 174 0.7× 295 1.7× 284 1.8× 69 0.8× 120 1.5× 33 892

Countries citing papers authored by Şeyda Gündüz

Since Specialization
Citations

This map shows the geographic impact of Şeyda Gündüz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şeyda Gündüz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şeyda Gündüz more than expected).

Fields of papers citing papers by Şeyda Gündüz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şeyda Gündüz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şeyda Gündüz. The network helps show where Şeyda Gündüz may publish in the future.

Co-authorship network of co-authors of Şeyda Gündüz

This figure shows the co-authorship network connecting the top 25 collaborators of Şeyda Gündüz. A scholar is included among the top collaborators of Şeyda Gündüz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şeyda Gündüz. Şeyda Gündüz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Albadawi, Hassan, Zefu Zhang, Hyeongseop Keum, et al.. (2024). Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics. Advanced Materials. 36(45). e2406080–e2406080. 3 indexed citations
4.
Albadawi, Hassan, Zefu Zhang, Jinjoo Kim, et al.. (2024). Catheter‐Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation. Advanced Materials. 36(29). e2402570–e2402570. 4 indexed citations
5.
Gündüz, Şeyda, Di̇lek Erdem, Deniz Can Güven, et al.. (2021). Ixabepilone in Metastatic Breast Cancer: Real-World Experience. 7(3). 85–90. 2 indexed citations
6.
Alva, Ajjai, Tibor Csőszi, Mustafa Özgüroğlu, et al.. (2021). Impact of subsequent therapy on survival in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as first-line therapy for advanced urothelial carcinoma (UC).. Journal of Clinical Oncology. 39(6_suppl). 439–439. 2 indexed citations
7.
Powles, Thomas, Tibor Csőszi, Mustafa Özgüroğlu, et al.. (2021). 1L pembrolizumab (pembro) versus chemotherapy (chemo) for choice-of-carboplatin patients with advanced urothelial carcinoma (UC) in KEYNOTE-361.. Journal of Clinical Oncology. 39(6_suppl). 450–450. 10 indexed citations
8.
Alva, Ajjai, Tibor Csőszi, Mustafa Özgüroğlu, et al.. (2020). LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361. Annals of Oncology. 31. S1155–S1155. 47 indexed citations
10.
Gündüz, Şeyda, et al.. (2016). Opioid endocrinopathy: A clinical problem in patients with cancer pain. Experimental and Therapeutic Medicine. 11(5). 1819–1822. 21 indexed citations
11.
Yıldırım, Mustafa, Vildan Kaya, Özlem Demirpençe, Şeyda Gündüz, & Hakan Bozcuk. (2015). Prognostic Significance of p53 in Gastric Cancer: a Meta-Analysis. Asian Pacific Journal of Cancer Prevention. 16(1). 327–332. 42 indexed citations
12.
Gündüz, Şeyda, et al.. (2014). Rising CEA Levels in a Patient with Colon Carcinoma: Metachronous Medullary Thyroid Cancer. The International Journal of Biological Markers. 29(2). 184–186. 5 indexed citations
13.
Yıldırım, Mustafa, Özlem Demirpençe, Vildan Kaya, et al.. (2014). Roles for Paraoxonase but not Ceruloplasmin in Peritoneal Washing Fluid in Differential Diagnosis of Gynecologic Pathologies. Asian Pacific Journal of Cancer Prevention. 15(15). 6233–6237. 1 indexed citations
14.
Mutlu, Hasan, Şeyda Gündüz, Abdullah Büyükçelik, et al.. (2014). The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b. Clinical Genitourinary Cancer. 12(6). 447–450. 6 indexed citations
15.
Artaç, Mehmet, Nazım Serdar Turhal, Murat Koçer, et al.. (2014). Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study.. PubMed. 100(2). 143–8. 18 indexed citations
16.
Gündüz, Şeyda, Hasan Mutlu, Sema Sezgin Göksu, et al.. (2014). Oral Cyclophosphamide and Etoposide in Treatment of Malignant Pleural Mesothelioma. Asian Pacific Journal of Cancer Prevention. 15(20). 8843–8846. 3 indexed citations
18.
Göksu, Sema Sezgin, Şeyda Gündüz, Dilek Ünal, et al.. (2014). Use of Blood Transfusion at the End of Life: Does it Have Any Effects on Survival of Cancer Patients?. Asian Pacific Journal of Cancer Prevention. 15(10). 4251–4254. 22 indexed citations
19.
Uysal, Mükremın, Hakan Bozcuk, Sema Sezgin Göksu, et al.. (2013). Pesticides and Cancer: The First Incidence Study Conducted in Turkey. Journal of Environmental Pathology Toxicology and Oncology. 32(3). 245–249. 10 indexed citations
20.
Tatlı, Ali Murat, et al.. (2013). Complete Response of Primary Bladder Adenocarcinoma with the FOLFOX4 Regimen. Urologia Internationalis. 94(3). 363–365. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026